Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 12Hyperandrogenism 3Menstruation Disturbances 2Insulin Resistance 2Overweight 1Metabolic Syndrome 1Infertility 1Hirsutism 1Amenorrhea 1

Interventions

Metformin 7Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2maltodextrin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hyperandrogenism × drospirenone and ethinyl estradiol combination × Clear all
NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

AGUNCO Obstetrics and Gynecology Centre

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡